Condensed Consolidated Statements of Redeemable Convertible Preferred Stock and Stockholder's Equity (Deficit) - USD ($) $ in Thousands	Total	Series A Convertible Preferred Stock	Common Stock	Additional Paid-in Capital	Additional Paid-in Capital Series A Convertible Preferred Stock	Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2021		0
Beginning balance at Dec. 31, 2021		$ 0
Ending balance (in shares) at Mar. 31, 2022		0
Ending balance at Mar. 31, 2022		$ 0
Beginning balance (in shares) at Dec. 31, 2021			8,071,183
Beginning balance at Dec. 31, 2021	$ 55,191		$ 1	$ 198,612		$ (143,422)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options (in Shares)			6,343
Issuance of common stock upon exercise of stock options	48			48
Issuance of common stock for restricted stock units vesting (in shares)			22,935
Stock-based compensation	3,336			3,336
Net loss	(28,758)					(28,758)
Ending balance (in shares) at Mar. 31, 2022			8,100,461
Ending balance at Mar. 31, 2022	29,817		$ 1	201,996		(172,180)
Beginning balance (in shares) at Dec. 31, 2021		0
Beginning balance at Dec. 31, 2021		$ 0
Ending balance (in shares) at Sep. 30, 2022		0
Ending balance at Sep. 30, 2022		$ 0
Beginning balance (in shares) at Dec. 31, 2021			8,071,183
Beginning balance at Dec. 31, 2021	55,191		$ 1	198,612		(143,422)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(59,838)
Ending balance (in shares) at Sep. 30, 2022			8,203,744
Ending balance at Sep. 30, 2022	4,419		$ 1	207,678		(203,260)
Beginning balance (in shares) at Mar. 31, 2022		0
Beginning balance at Mar. 31, 2022		$ 0
Ending balance (in shares) at Jun. 30, 2022		0
Ending balance at Jun. 30, 2022		$ 0
Beginning balance (in shares) at Mar. 31, 2022			8,100,461
Beginning balance at Mar. 31, 2022	29,817		$ 1	201,996		(172,180)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options (in Shares)			29,866
Issuance of common stock upon exercise of stock options	166			166
Issuance of common stock for restricted stock units vesting (in shares)			16,454
Stock-based compensation	3,273			3,273
Net loss	(11,718)					(11,718)
Ending balance (in shares) at Jun. 30, 2022			8,146,781
Ending balance at Jun. 30, 2022	21,538		$ 1	205,435		(183,898)
Ending balance (in shares) at Sep. 30, 2022		0
Ending balance at Sep. 30, 2022		$ 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options (in Shares)			21,786
Issuance of common stock upon exercise of stock options	41			41
Issuance of common stock for restricted stock units vesting (in shares)			17,328
Issuance of common stock for employee stock purchase plans			17,849
Issuance of common stock for employee stock purchase plan	359			359
Stock-based compensation	1,843			1,843
Net loss	(19,362)					(19,362)
Ending balance (in shares) at Sep. 30, 2022			8,203,744
Ending balance at Sep. 30, 2022	4,419		$ 1	207,678		(203,260)
Beginning balance (in shares) at Dec. 31, 2022		0
Beginning balance at Dec. 31, 2022		$ 0
Increase (Decrease) in Temporary Equity [Roll Forward]
Temporary equity, shares issued (in shares)		30,000
Issuance of Series A convertible preferred stock		$ 3,867
Preferred stock issuance costs		(253)
Accretion on Series A convertible preferred stock	(653)	$ 653			$ (653)
Ending balance (in shares) at Mar. 31, 2023		30,000
Ending balance at Mar. 31, 2023		$ 4,267
Beginning balance (in shares) at Dec. 31, 2022			8,242,009
Beginning balance at Dec. 31, 2022	(10,635)		$ 1	212,122		(222,758)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Preferred stock issuance costs	0			0
Issuance of SVB Warrants (Note 4)	43			43
Issuance of common stock upon exercise of stock options (in Shares)			18,054
Issuance of common stock upon exercise of stock options	55			55
Issuance of common stock for restricted stock units vesting (in shares)			115,257
Issuance of common stock for employee stock purchase plans			15,104
Issuance of common stock for employee stock purchase plan	101			101
Stock-based compensation	2,789			2,789
Net loss	(11,867)					(11,867)
Ending balance (in shares) at Mar. 31, 2023			8,390,424
Ending balance at Mar. 31, 2023	(20,167)		$ 1	214,457		(234,625)
Beginning balance (in shares) at Dec. 31, 2022		0
Beginning balance at Dec. 31, 2022		$ 0
Ending balance (in shares) at Sep. 30, 2023		30,000
Ending balance at Sep. 30, 2023		$ 6,912
Beginning balance (in shares) at Dec. 31, 2022			8,242,009
Beginning balance at Dec. 31, 2022	(10,635)		$ 1	212,122		(222,758)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(25,975)
Ending balance (in shares) at Sep. 30, 2023			8,563,301
Ending balance at Sep. 30, 2023	(31,952)		$ 1	216,780		(248,733)
Beginning balance (in shares) at Mar. 31, 2023		30,000
Beginning balance at Mar. 31, 2023		$ 4,267
Increase (Decrease) in Temporary Equity [Roll Forward]
Accretion on Series A convertible preferred stock	(1,326)	$ 1,326			(1,326)
Ending balance (in shares) at Jun. 30, 2023		30,000
Ending balance at Jun. 30, 2023		$ 5,593
Beginning balance (in shares) at Mar. 31, 2023			8,390,424
Beginning balance at Mar. 31, 2023	(20,167)		$ 1	214,457		(234,625)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock for restricted stock units vesting (in shares)			51,259
Stock-based compensation	2,644			2,644
Net loss	(8,467)					(8,467)
Ending balance (in shares) at Jun. 30, 2023			8,441,683
Ending balance at Jun. 30, 2023	(27,316)		$ 1	215,775		(243,092)
Increase (Decrease) in Temporary Equity [Roll Forward]
Accretion on Series A convertible preferred stock	(1,319)	$ 1,319			$ (1,319)
Ending balance (in shares) at Sep. 30, 2023		30,000
Ending balance at Sep. 30, 2023		$ 6,912
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock for restricted stock units vesting (in shares)			93,525
Issuance of common stock for employee stock purchase plans			28,093
Issuance of common stock for employee stock purchase plan	114			114
Stock-based compensation	2,210			2,210
Net loss	(5,641)					(5,641)
Ending balance (in shares) at Sep. 30, 2023			8,563,301
Ending balance at Sep. 30, 2023	$ (31,952)		$ 1	$ 216,780		$ (248,733)